Table 4.
Additional variables for consideration in a prognostic classification system
| Component | Not Closed N (%) |
Closed N (%) |
RR (95% CI) |
|---|---|---|---|
| Patient characteristics | |||
| Age > 25 | 65 (55.1) | 241 (46.4) | 1.10 (0.77-1.56) |
| Duration of fistula (average years, sd) | 5.5 ( 8.3) | 3.0 ( 4.7) | 1.04(1.03-1.06)** |
| Comorbidities present at baseline | |||
| Genital cutting | 35 (29.7) | 99 (19.2) | 1.31 (0.88-1.95) |
| Malnutrition | 8 ( 6.8) | 31 ( 6.0) | 1.01 (0.46-2.22) |
| Anemia | 9 ( 7.6) | 36 ( 6.9) | 0.88 (0.62-1.24) |
| UTI | 0 ( 0.0) | 2 ( 0.4) | - |
| HIV | 0 ( 0.0) | 2 ( 0.4) | - |
| Malaria | 1 ( 0.8) | 3 ( 0.6) | 0.93 (0.33-2.66) |
| Fistula characteristics and/or categorizations of fistula characteristics not included in above classification systems | |||
| Necrotic tissue present | 16 (13.7) | 46 ( 8.9) | 1.33 (0.61-2.86) |
| No or mild scarring | 51 (43.2) | 356 (68.7) | Ref |
| Moderate scarring | 43 (36.4) | 133 (25.7) | 1.74 (1.08-2.82)** |
| Severe scarring | 24 (20.3) | 29 ( 5.6) | 3.27 (1.91-5.68)** |
| No urethral involvement | 46 (39.0) | 326 (62.9) | Ref |
| Partial urethral involvement | 30 (25.4) | 119 (23.0) | 1.52 (1.12-2.07)** |
| Complete destruction or transection / circumferential injury |
41 (35.0) | 72 (14.0) | 2.65 (1.87-3.76)** |
| Non-vvf (ureteric, urethral, rectovaginal, cervical fistula) |
78 (66.7) | 266 (51.6) | 1.71 (1.19-2.44)** |
| Cervix not visible | 27 (22.9) | 79 (15.4) | 1.43 (0.89 -2.72)* |
**
p-value <.05
*
p-value <.20